Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma

TORU ISHIKAWA; RYO SATO; RYO JIMBO; YUJI KOBAYASHI; TOSHIFUMI SATO; AKITO IWANAGA; TOMOE SANO; JUNJI YOKOYAMA; TERASU HONMA

doi:10.21873/invivo.13721

Article Information

vol. 38 no. 5 2501-2505

DOI

https://doi.org/10.21873/invivo.13721

PMID

39187329

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received May 29, 2024
Revision received June 17, 2024
Accepted June 18, 2024
Published online August 26, 2024.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

TORU ISHIKAWA ⇑,
RYO SATO,
RYO JIMBO,
YUJI KOBAYASHI,
TOSHIFUMI SATO,
AKITO IWANAGA,
TOMOE SANO,
JUNJI YOKOYAMA and
TERASU HONMA

Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan

Correspondence to: Toru Ishikawa (ORCID: 0000-0002-5470-9694), MD, Ph.D., Director, Department of Gastroenterology, Saiseikai Niigata Hospital, Teraji 280-7, Niigata 950-1104, Japan. Tel: +81 252336161, Fax: +81 252338880, e-mail: toruishi{at}ngt.saiseikai.or.jp

View Full Text